Auvinen et al. examine genome-wide DNA methylation, imprinting, and gene expression in human placentas. Placentas from assisted reproductive technologies experience a variety of altered signaling ...

After NBC's reporting on a large hospital system that placed liens on homes of patients who owed medical debt, the company removed the liens and canceled judgments against thousands of patients.

This year, STAT published a cornucopia of stories on health and medicine, bringing our signature analysis, insight, and investigative skills to readers. Here’s a sampling of some of the ...

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report)’s share price traded down 4.6% during mid-day trading on Monday after an insider sold shares in the company.The stock traded as low as $52. ...

NASDAQ:NARI opened at $54.41 on Tuesday. The stock has a market cap of $3.19 billion, a price-to-earnings ratio of -40.30 and a beta of 0.97. Inari Medical has a one year low of $36.73 and a one ...

A diagnostic medical sonographer could be answering the question "Is it a boy or a girl?" as well as a host of other life-changing medical questions with the help of ultrasound technology.

https://www.tipranks.com/news/the-fly/biontech-to-pay-791-5m-in-settlement-agreement-with-the-nih Truist analyst Richard Newitter raised the firm’s price target on ...

The findings revealed that the use of acetaminophen – sometimes also called paracetamol – was associated with an increased risk of serious medical complications. This includes peptic ulcer ...

(Photo by Evan Agostini/Invision/AP, File) MacKenzie Scott continues to make medical debt relief a priority in her mysterious giving. This week, Undue Medical Debt, formerly RIP Medical Debt, ...

Alberta woman's medically assisted death delayed last minute by B.C. judge "JMM received approval for medical assistance in dying, but he subsequently expressed that he did not wish to proceed ...

Truist analyst Richard Newitter raised the firm’s price target on Inari Medical (NARI) to $63 from $50 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in ...